Paratesticular leiomyosarcomas are rare and can lead to significant morbidity and mortality, if inadequately diagnosed or treated. We present a case of paratesticular leiomyosarcoma in an 88-year-old man presenting with a left scrotal mass with ultrasound revealing that the mass is extratesticular. Left radical orchidectomy was performed and pathological examination of the resected specimen confirmed the diagnoses of high grade leiomyosarcoma with surgical margins clear of tumour. The patient was free of metastatic disease on further imaging and has been disease-free for 18 months. A review of the literature regarding paratesticular leiomyosarcoma presentation, diagnosis, and treatment is also discussed. 1. Introduction We report the first documented case of paratesticular leiomyosarcoma diagnosed and treated in Australia. A review of the literature regarding paratesticular leiomyosarcoma presentation, diagnosis, and treatment is also discussed. 2. Case An 88-year-old male presented to his urologist with a tender swelling of his left testicle. There were no associated lower urinary tract or constitutional symptoms. His past history included prostate adenocarcinoma diagnosed 13 years prior to presentation, for which he had undergone transurethral resection of the prostate and regular monitoring. Physical examination revealed a 2?cm swelling arising from the upper pole of the left testicle. The mass was subcutaneous, firm, and tender. Scrotal ultrasonography identified a left sided hydrocele as well as an altered area of echogenicity at the upper pole of the left testis extending into the epididymis measuring approximately 15?mm in diameter. Prostate specific antigen was unchanged from previous measurements. The patient underwent an elective left radical orchidectomy. The surgical specimen weighing 75?g consisted of testis, epididymis, and spermatic cord. It contained a 35 × 30 × 26?mm firm mass centred on paratesticular tissues adjacent to the upper pole of the left testis extending into the epididymis with a grey/white cut surface. Histologically, the tumour consisted of interweaving fascicles of cytologically malignant spindle shaped cells (Figure 1) with frequently bizarre nuclei. Abnormal mitotic figures were scattered throughout the lesion (Figure 2) and focal tumour necrosis was identified. The radial and spermatic cord resection margins were within normal tissue. Immunohistochemical stains were strongly positive for vimentin and smooth muscle actin (Figure 3). Histological features were consistent with a diagnosis of high grade leiomyosarcoma.
References
[1]
R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2012,” CA Cancer Journal for Clinicians, vol. 62, no. 1, pp. 10–29, 2012.
[2]
A. Stojadinovic, D. H. Y. Leung, P. Allen, J. J. Lewis, D. P. Jaques, and M. F. Brennan, “Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables,” Journal of Clinical Oncology, vol. 20, no. 21, pp. 4344–4352, 2002.
[3]
B. Khoubehi, V. Mishra, M. Ali, H. Motiwala, and O. Karim, “Adult paratesticular tumours,” BJU International, vol. 90, no. 7, pp. 707–715, 2002.
[4]
M. Mechri, S. Ghozzi, R. Khiari, F. Bougrine, A. Bouziani, and N. BenRais, “A rare cause of a scrotal mass: primary leiomyosarcoma of epididymis,” BMJ Case Reports, 2009.
[5]
D. Rodriguez and A. F. Olumi, “Management of spermatic cord tumors: a rare urological malignancy,” Therapeutic Advances in Urology, vol. 4, no. 6, pp. 325–334, 2012.
[6]
J. Moloney, J. Drumm, and D. M. Fanning, “A rare case of paratesticular leiomyosarcoma,” Clinics and Practice, vol. 2, p. e29, 2012.
[7]
P. Dangle, D. R. Basavaraj, S. Bhattarai, A. B. Paul, and C. S. Biyani, “Leiomyosarcoma of the spermatic cord: case report and literature review,” Canadian Urological Association Journal, vol. 1, no. 1, pp. 55–58, 2007.
[8]
V. T. Yuen, S. D. Kirby, and Y. C. Woo, “Leiomyosarcoma of the epididymis: 2 cases and review of the literature,” Journal of the Canadian Urological Association, vol. 5, no. 6, pp. E121–E124, 2011.
[9]
A. L. Folpe and S. W. Weiss, “Paratesticular soft tissue neoplasms,” Seminars in Diagnostic Pathology, vol. 17, no. 4, pp. 307–318, 2000.
[10]
M. T. Ballo, G. K. Zagars, P. W. T. Pisters, B. W. Feig, S. R. Patel, and A. C. Von Eschenbach, “Spermatic cord sarcoma: outcome, patterns of failure and management,” Journal of Urology, vol. 166, no. 4, pp. 1306–1310, 2001.
[11]
P. Mohammadi Torbati and H. Zham, “Epithelioid type of paratesticular leiomyosarcoma: a case report and literature review,” Journal of Urology, vol. 1, no. 3, pp. 215–217, 2004.
[12]
M. C. Frates, C. B. Benson, D. N. DiSalvo, D. L. Brown, F. C. Laing, and P. M. Doubilet, “Solid extratesticular masses evaluated with sonography: pathologic correlation,” Radiology, vol. 204, no. 1, pp. 43–46, 1997.
[13]
L. B. Weinshank, D. Kellner, and I. Nash, “Paratesticular leiomyosarcoma: case report and review,” Connecticut Medicine, vol. 75, no. 7, pp. 399–403, 2011.
[14]
I. Kyratzi, E. Lolis, E. Antypa, M. A. Lianou, and D. Exarhos, “Imaging features of a huge spermatic cord leiomyosarcoma: review of the literature,” World Journal of Radiology, vol. 3, no. 4, pp. 114–119, 2011.
[15]
H. Hashimoto, Y. Daimaru, M. Tsuneyoshi, and M. Enjoji, “Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study,” Cancer, vol. 57, no. 10, pp. 2077–2088, 1986.
[16]
A. G. Wile, H. L. Evans, and M. M. Romsdahl, “Leiomyosarcoma of soft tissue: a clinicopathologic study,” Cancer, vol. 48, no. 4, pp. 1022–1032, 1981.
[17]
C. Fisher, J. R. Goldblum, J. I. Epstein, and E. Montgomery, “Leiomyosarcoma of the paratesticular region. A clinicopathologic study,” American Journal of Surgical Pathology, vol. 25, no. 9, pp. 1143–1149, 2001.
[18]
P. H. Blitzer, D. E. Dosoretz, K. H. Proppe, and W. U. Shipley, “Treatment of malignant tumors of the spermatic cord: a study of 10 cases and a review of the literature,” Journal of Urology, vol. 126, no. 5, pp. 611–614, 1981.
[19]
O. Merimsky, P. Terrier, S. Bonvalot, C. Le Pechoux, J. Delord, and A. Le Cesne, “Spermatic cord sarcoma in adults,” Acta Oncologica, vol. 38, no. 5, pp. 635–638, 1999.
[20]
M. A. Fagundes, A. L. Zietman, A. F. Althausen, J. J. Coen, and W. U. Shipley, “The management of spermatic cord sarcoma,” Cancer, vol. 77, no. 9, pp. 1873–1876, 1996.
[21]
J. Coleman, M. F. Brennan, K. Alektiar, and P. Russo, “Adult spermatic cord sarcomas: management and results,” Annals of Surgical Oncology, vol. 10, no. 6, pp. 669–675, 2003.
[22]
L. H. Banowsky and G. N. Shultz, “Sarcoma of the spermatic cord and tunics: review of the literature, case report and discussion of the role of retroperitoneal lymph node dissection,” Journal of Urology, vol. 103, no. 5, pp. 628–631, 1970.
[23]
H. C. Bauer, T. A. Alveg?rd, ?. Berlin et al., “The Scandinavian Sarcoma Group Register 1986-2001,” Acta Orthopaedica Scandinavica, Supplement, vol. 75, supplement 311, pp. 8–10, 2004.
[24]
C. Catton, B. J. Cummings, V. Fornasier, B. O'Sullivan, I. Quirt, and D. Warr, “Adult paratesticular sarcomas: a review of 21 cases,” Journal of Urology, vol. 146, no. 2, pp. 342–345, 1991.
[25]
J. F. Tierney, “Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data,” The Lancet, vol. 350, no. 9092, pp. 1647–1654, 1997.
[26]
P. J. Woll, P. Reichardt, A. Le Cesne, et al., “Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial,” Journal of Clinical Oncology, vol. 25, supplement 18, Article ID 10008, 2007.
[27]
B. S. Ko, N. Y. Kim, A. J. Ryu, et al., “A case of paratesticular leiomyosarcoma successfully treated with orchidectomy and chemotherapy,” Cancer Treatment and Research, vol. 44, no. 3, pp. 210–214, 2012.